EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

LDL-cholesterol target levels achievement in high-risk patients: An (un)expected gender bias

Martina Berteotti, Francesco Profili, Besmir Nreu, Giancarlo Casolo, Alfredo Zuppiroli, Edoardo Mannucci, Rossella Marcucci, Paolo Francesconi

Nutrition, Metabolism and Cardiovascular Diseases · 2024-01 · 34 (1) · 145-152

DOI: 10.1016/j.numecd.2023.09.023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2024-01. Verfasst von Martina Berteotti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: martina.berteotti@unifi.it. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Lowering low-density lipoprotein cholesterol (LDL-C) is the cornerstone of cardiovascular disease prevention. Collection of epidemiological data is crucial for monitoring healthcare appropriateness. This analysis aimed to evaluate the proportion of high-risk patients who achieved guidelines recommended LDL-C goal, and explore the predictors of therapeutic failure, with a focus on the role of gender. METHODS AND RESULTS: Health administrative and laboratory data from seven Local Health Districts in Tuscany were collected for residents aged ≥45 years with a history of major adverse cardiac or cerebrovascular event (MACCE) and/or type 2 diabetes mellitus (T2DM) from January 1, 2019, to January 1, 2021. The study aimed to assess the number of patients with optimal levels of LDL-C (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Cardiovascular DiseasesHydroxymethylglutaryl-CoA Reductase InhibitorsHumansFemaleMaleCholesterol, LDLSexismRisk Factors

Stichwörter der Autor:innen

Diabetes mellitusLDL-C targetLipid lowering therapyMACCE

Substanzen

Cholesterol, LDLHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: martina.berteotti@unifi.it.
  • Epidemiology Unit, Regional Health Agency (ARS) of Tuscany, Florence, Italy.
  • Diabetology Unit, Careggi university hospital, Florence, Italy.
  • Cardiology Unit, Versilia Hospital, Lido di Camaiore, Italy.
  • Former Department of Cardiology, Azienda Sanitaria di Firenze, Florence, Italy.
  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Diabetology Unit, Careggi university hospital, Florence, Italy.

Zitieren

APA

Berteotti, M., Profili, F., Nreu, B., Casolo, G., Zuppiroli, A., Mannucci, E., Marcucci, R., & Francesconi, P. (2024). LDL-cholesterol target levels achievement in high-risk patients: An (un)expected gender bias. Nutrition, Metabolism and Cardiovascular Diseases, 34(1), 145-152. https://doi.org/10.1016/j.numecd.2023.09.023

Vancouver

Berteotti M, Profili F, Nreu B, Casolo G, Zuppiroli A, Mannucci E, et al. LDL-cholesterol target levels achievement in high-risk patients: An (un)expected gender bias. Nutrition, Metabolism and Cardiovascular Diseases. 2024;34(1):145-152. doi:10.1016/j.numecd.2023.09.023

BibTeX
@article{Berteotti2024,
  author = {Berteotti, Martina and Profili, Francesco and Nreu, Besmir and Casolo, Giancarlo and Zuppiroli, Alfredo and Mannucci, Edoardo and Marcucci, Rossella and Francesconi, Paolo},
  title = {LDL-cholesterol target levels achievement in high-risk patients: An (un)expected gender bias},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2024},
  volume = {34},
  number = {1},
  pages = {145--152},
  doi = {10.1016/j.numecd.2023.09.023}
}
Kostenlos starten →